➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Johnson and Johnson
Colorcon
Mallinckrodt
Harvard Business School

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Litigation Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 8,420,663 (“the ’663 patent”); 8,524,276 (“the ’276 patent”); 8,956,651 (“…. 208271, the ’663 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent are listed in the FDA…related to the ’663 patent, ’276 patent, ’651 patent, ’125 patent, or ’461 patent. 30. Upon information…expiration of the ’663 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent or such later date …17 PageID: 16 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent or such later date External link to document
0000-00-00 180 Letter asserting claims for infringement of U.S. Patent No. 10,307,417. (DENI, WILLIAM) (Entered: 06/14/2019) …2016 3 December 2019 2:16-cv-09038 830 Patent None District Court, D. New Jersey External link to document
0000-00-00 187 Actavis.”) Plaintiffs own U.S. Patent No. 8,524,276 (“the ’276 patent”), which is listed in the Orange…. 15. Claims 2 and 5 of U.S. Patent No. 8,524,276 are valid patent claims. 16. Plaintiffs have proven… the 1970s. ’276 patent, col.1 ll.62- 3. U.S. Patent No. 6,559,158 (the “’158 patent”), filed in 2000…formulation. ’276 patent, col.2 ll.27-41. U.S. Patent No. 6,274,591 (the “’591 patent”) claimed a method…infringed the ’276 patent. A bench trial on both infringement and Actavis’ patent invalidity defenses External link to document
0000-00-00 188 infringement of the valid claims 2 and 5 of U.S. Patent No. 8,524,276, and Judgment on Count III of the Complaint…asserting the invalidity of claims 2 and 5 of the 276 patent due to obviousness, is hereby entered in Plaintiffs…2016 3 December 2019 2:16-cv-09038 830 Patent None District Court, D. New Jersey External link to document
0000-00-00 189 than the date of the expiration of U.S. Patent No. 8,524,276. Signed by Judge Stanley R. Chesler on 7…2016 3 December 2019 2:16-cv-09038 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKinsey
Express Scripts
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.